Larimar Therapeutics Analyst Ratings

Benzinga07:00 ET · Ratings

H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15

Moomoo News06:31 ET · Ratings

Larimar Therapeutics' Promising Developments and Strategic Positioning Signal Buy Opportunity

TipRanks18:25 ET

Express News | Larimar Therapeutics Inc - to Initiate Cohort of Children 2-11 Years Old in 1H 2025

Reuters16:05 ET

Express News | Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-in Study for Patients With Friedreich’s Ataxia

Reuters16:05 ET

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients With Friedreich's Ataxia

GlobeNewswire16:05 ET